Related by context. All words. (Click for frequent words.) 71 kidney urologic 64 Leukemias 64 Systemic lupus erythematosus SLE 64 alpha1 antitrypsin deficiency 64 LHON 64 inflammatory demyelinating 63 haematologic 63 Nonalcoholic fatty liver 63 diabetes mellitus DM 63 aMCI precursor 63 Waldenstrom macroglobulinemia 62 lymphomas leukemias 62 severe hepatic dysfunction 62 Pharmacologic 62 AA Amyloidosis 62 antibody mediated 62 Rheumatoid Arthritis RA 61 Asthma COPD 61 PCNSL 61 hematopoietic cancers 61 Chronic lymphocytic leukemia 61 Acute myeloid leukemia 61 neuropsychiatric disorder 61 acadesine 61 Hypertriglyceridemia 61 chronic myeloid 61 transgenic mouse models 61 ANCA associated 61 papillary renal cell carcinoma 61 constipation predominant irritable bowel 61 endocrine diseases 61 Magnesium deficiency 61 Wadih Arap 61 pDC 61 Cardiotoxicity 60 metaglidasen 60 Hematological 60 neuropathologic 60 SSc 60 cisplatin resistant 60 1 diabetes T1D 60 PORxin TM platforms 60 PLX STROKE targeting 60 Autoimmune Disease 60 immunotherapeutic approaches 60 immunocompetent 60 pancreatic adenocarcinoma 60 Autoimmune Disorders 60 dyskeratosis congenita 60 relapsed MM 60 Mutational 60 gastric carcinoma 60 squamous cell lung cancer 60 lymphoid tumors 60 Hyperuricemia 60 recurrent glioma 59 clinicopathological 59 HIV HCV coinfected 59 metastatic malignant 59 CP CPPS 59 comorbid anxiety 59 neovascular 59 systemic autoimmune 59 pulmonary hypertension PH 59 Cytogenetic 59 novel chimeric natriuretic 59 Hematologic 59 lupus scleroderma 59 MELAS 59 T1DM 59 metastatic neuroendocrine tumors 59 cystic fibrosis chronic pancreatitis 59 bronchoalveolar lavage fluid 59 HIV coinfected 59 haematopoietic 59 Chlamydia trachomatis infection 59 Gastro intestinal 59 BRAF V#E 59 LRP5 59 bought Glaxo Serevent 59 humanized therapeutic 59 induced tumor regression 59 Introgen ADVEXIN 59 epithelial tumors 59 left ventricular diastolic 59 Neovascular Age Related Macular 59 Iron Overload 59 unresectable tumors 59 Inflammatory Bowel Diseases 59 systemic lupus erythematosus 59 Idiopathic pulmonary fibrosis IPF 59 gastroenterology neurology 59 cutaneous lupus 59 lymphoproliferative disorders 59 Haptoglobin 59 Prostatitis 59 myeloproliferative neoplasms 59 HER2 overexpression 59 metastatic pancreatic 59 Sjögren syndrome 59 Myelofibrosis 59 Diabetes diabetes mellitus 59 neuroendocrine cancers 59 gastrointestinal stromal tumors GISTs 59 Omacetaxine 59 atypical hemolytic uremic syndrome 59 RRM1 59 HuCNS SC ® 59 prostate carcinogenesis 59 diabetic kidney 59 dominantly inherited 59 ErbB1 59 leiomyomas 59 hepatic cirrhosis 58 Parkinson Disease PD 58 Dr. Bezprozvanny 58 pharmacogenomic translational research 58 hypovitaminosis D 58 Hematopoietic 58 psoriatic arthritis PsA 58 obesity insulin resistance 58 systemic amyloidosis 58 interleukin IL -# 58 AAT Deficiency 58 transgenic rats 58 essential thrombocythemia ET 58 inflammation metabolic disorders 58 KRAS oncogene 58 NIDDM 58 breast endometrial 58 Alimentary Tract 58 mucinous 58 hereditary emphysema 58 impaired glucose metabolism 58 Cancer cachexia 58 Neuroprotection 58 Clusterin 58 Teriflunomide 58 prostate cancer CaP 58 progressive neurodegenerative 58 nonmelanoma 58 Chemotherapy induced 58 E selectin 58 prospective multicentre 58 hypertension cardiovascular disease 58 colorectal carcinoma 58 neuropathic pain spasticity 58 Prolongs Survival 58 interferon alpha IFN alpha 58 metastatic gastric 58 smoldering myeloma 58 Severe Primary IGFD 58 Atopic dermatitis 58 receptor inhibitor 58 neurofibrillary 58 Atherosclerotic 58 chronic rheumatic 58 Chronic myeloid leukemia 58 hepatic fibrosis 58 Preclinical Study 58 Microalbuminuria 58 chronic periodontitis 58 Myelodysplastic Syndrome 58 demonstrated antitumor activity 58 K ras mutations 58 Hyperlipidemia 58 monogenic 58 Chronic HCV 58 Acute Liver Failure 58 PLX MS 58 NOMID 58 gastric carcinogenesis 58 tryptase 58 Gleevec resistant 58 SinuNase ™ 58 Insulin Resistance 58 Chronic Fatigue Syndrome CFS 58 Soft Tissue Sarcoma 58 chronic granulomatous disease 58 Systemic Lupus Erythematosus 58 histological subtype 58 monocytes macrophages 58 nutlin 3a 58 Cutaneous T 57 Glioma 57 progressive neurodegenerative disorder 57 Goltz syndrome 57 Adenomas 57 Tor Bjerkedal report 57 GRNCM1 57 STAT4 57 infectious diseases autoimmune diseases 57 asthma rheumatoid arthritis 57 thyrotropin 57 siRNA knockdown 57 respiratory gastrointestinal 57 Relapsing Remitting Multiple Sclerosis 57 Iron deficiency anemia 57 EGFR HER2 57 Acute lymphoblastic leukemia 57 histologic subtype 57 allergic airway inflammation 57 RhuDex R 57 pancreas esophagus 57 commercialize deforolimus 57 Schizoaffective Disorder 57 next generation URAT1 57 GI motility disorders 57 Epidermal Growth Factor Receptor 57 RhuDex ™ 57 erythematosus 57 squamous cell carcinoma SCC 57 valvular heart disease 57 childbearing age mirrors 57 MELAS syndrome 57 experimental autoimmune encephalomyelitis 57 discoid lupus 57 hematopoietic cell 57 MYH9 gene 57 systemic lupus erythematosus SLE 57 debilitating autoimmune 57 number NCT# ClinicalTrials.gov 57 constipation OIC 57 primary hyperparathyroidism 57 Autoimmune Diseases 57 fulminant hepatic failure 57 Venous thromboembolism 57 monocytic 57 Frontotemporal Dementia 57 testicular germ cell 57 basal cell nevus syndrome 57 Chronic Heart Failure 57 serum lipid levels 57 Cytotoxic T 57 renal cell carcinomas 57 Systemic lupus 57 Aortic stenosis 57 interferon γ 57 Systemic Sclerosis 57 Leber congenital amaurosis LCA 57 Bronchiectasis 57 Chronic Sinusitis 57 polyarticular 57 hormonal abnormalities 57 Idiopathic Pulmonary Fibrosis IPF 57 cisplatin gemcitabine 57 Huntingtons disease 57 Multiple Myeloma MM 57 dasatinib Sprycel 57 evaluating mipomersen 57 #q# deletion 57 invasive candidiasis 57 #q# deletion syndrome 57 cervical prostate 57 ADPKD 57 lupus anticoagulant 57 Epstein Barr Virus 57 Acute Ischemic Stroke 57 Urinary tract 57 JAK2 enzyme 57 steroid refractory 57 PsA 57 B streptococcal 57 Symadex 57 Quinamed 57 Nilotinib 57 androgen dependent 57 ASCO GU 57 Hill Rom enhancing 57 recurrent glioblastoma multiforme 57 Val HeFT 57 pathological hallmark 57 Juvenile Idiopathic Arthritis 57 psoriasis rheumatoid arthritis 57 abnormal lymphocytes 57 author Xiang Gao 57 essential thrombocythemia 57 Mark Tuszynski 57 GH deficiency 57 Polycystic Ovary Syndrome 57 Carcinoid tumors 57 Progressive Multifocal Leukoencephalopathy 57 urogenital 56 Hepatocellular Carcinoma HCC 56 reproductive abnormalities 56 myeloproliferative diseases 56 lupus multiple sclerosis 56 Autoimmune 56 urothelial 56 motor neuron degeneration 56 Biological Therapy 56 secondary hyperparathyroidism 56 immunoregulation 56 glaucoma cataract 56 lymphoid organs 56 demyelinating 56 ADVEXIN therapy 56 Polycystic ovary syndrome PCOS 56 synovial tissue 56 Phase IIA 56 antiretroviral naïve 56 thromboembolic disease 56 Mol Med 56 ASCO Breast Cancer 56 Endometrial 56 Chronic myeloid leukemia CML 56 prostate carcinoma 56 Myelodysplastic Syndrome MDS 56 Raf MEK ERK 56 vidofludimus 56 JAK2 Inhibitor 56 gastric adenocarcinoma 56 cardiac dysfunction 56 torsade de pointes 56 myeloproliferative disorders 56 prospective multicenter study 56 Eosinophilic Esophagitis 56 atypical Hemolytic Uremic Syndrome 56 colorectal adenoma 56 hereditary spastic paraplegia 56 abnormal angiogenesis 56 idiopathic thrombocytopenic purpura 56 hypereosinophilic syndrome 56 Pancreas Cancer 56 Renata Pasqualini 56 bronchial hyperresponsiveness 56 lung fibrosis 56 rheumatoid arthritis lupus 56 esophageal squamous cell carcinoma 56 rheumatologic 56 VIPR2 56 Leber Congenital Amaurosis LCA 56 amyloid plaque formation 56 renal allograft 56 lysosomal storage disease 56 Subtype 56 SIADH 56 Beta catenin pathway 56 PAOD 56 INxin 56 arterial calcification 56 CDH1 56 Diabetic neuropathy 56 osteosarcomas 56 Unstable Angina 56 syngeneic 56 hypophosphatasia 56 fibrous tangles 56 neurotrophic 56 Systemic Lupus Erythematosus SLE 56 differential gene expression 56 Polymorphisms 56 By JENNIFER LEARN 56 Carcinoid 56 chronic renal disease 56 postoperative pulmonary 56 Proc Am Soc 56 Prospective Randomized 56 oncology dermatology 56 endometrial hyperplasia 56 polycythemia vera essential thrombocythemia 56 neuritic 56 hereditary predisposition 56 inflammatory rheumatic 56 neurosensory 56 Enlarged prostate 56 myeloproliferative disease 56 Elestrin ® 56 Bradley Boeve 56 Targeted Anticancer Therapies 56 Adrenergic 56 Parkinson disease neurodegenerative disorder 56 Intravenous immunoglobulin 56 dysfunction Zada 56 Sezary syndrome 56 Oral NKTR 56 Immune Thrombocytopenic Purpura 56 R roscovitine 56 busulfan 56 autoimmune thyroid 56 rheumatic disorders 56 Evidence Therapeutic 56 urothelial cancer 56 Kahalalide F 56 cisplatin chemotherapy 56 destroys myelin 56 microglial 56 bone marrow lymph nodes 56 hypothalamic amenorrhea 56 autoantigen 56 hA# 56 Relapsing remitting 56 visceral metastases 56 allogeneic hematopoietic stem cell 56 Gastric Cancer 56 carcinoid tumors 56 patientswith 56 precancerous tumors 56 demyelinating disease 56 phosphorylated tau 56 cancerdefine 56 Hsp# Inhibitor 56 Alzheimer Disease AD 56 Fibromyalgia Syndrome 56 GPC5 56 BMPR2 56 Neuropathic 56 Patellofemoral 56 Myotonic dystrophy 56 huN# DM1 56 Beta Amyloid 56 Bullous 56 osteoprotegerin 56 lymphoid malignancies 56 degenerative neurological diseases 56 Neurogenic 56 Sjogren Syndrome 56 Estrogen Receptor 56 mycobacterial 56 commercialize CorMedix drug 56 AAT deficiency 56 Advanced Renal Cell 56 Polycythemia Vera 56 Rectal cancer 56 vinca alkaloid 56 MCyR 56 Pegylated Interferon 56 BRCA1 BRCA2 56 urolithiasis 56 Ankylosing spondylitis 56 Chronic Cerebrospinal Venous Insufficiency 56 LymphoStat B belimumab 56 CRLX# 56 Bosutinib 56 ovarian carcinoma 56 Multiple sclerosis MS 56 #ß HSD1 56 hereditary hemochromatosis 56 myelin protective sheath 56 cardiac allograft vasculopathy 56 esophageal reflux 56 thetreatment 56 ALK inhibitors 55 cardiovascular metabolic 55 paclitaxel poliglumex 55 Guoping Feng 55 neurite outgrowth 55 Interstitial cystitis 55 skeletal muscle weakness 55 Solid Tumors 55 ECTRIMS 55 neuro vascular 55 follicular lymphomas 55 thoracic aortic aneurysm 55 evaluating tivozanib 55 HCV NS5B polymerase 55 PSN# [002] 55 pulmonary metastasis 55 Leydig cell 55 serum leptin 55 congenital hyperinsulinism 55 airway hyperresponsiveness 55 atopic asthma 55 inducible nitric oxide synthase 55 metachronous 55 cardio renal 55 AGHD 55 poly ICLC 55 genitourinary cancers 55 cachexia anti infectives 55 Islet Transplantation 55 Osteoarthritis OA 55 Christos Mantzoros 55 receiving XGEVA 55 Novel Therapeutic 55 oncogenic transformation 55 Plasmodium falciparum malaria 55 autoimmune encephalitis 55 Irritable bowel syndrome IBS 55 Endometrial Cancer 55 thalidomide Thalomid 55 Alessio Fasano MD 55 elevated serum ALT 55 immunological diseases 55 seminomas 55 colorectal tumor 55 Irritable Bowel Syndrome IBS 55 Akt signaling 55 Non Hodgkins lymphoma 55 Hepatocellular Carcinoma 55 CIPN 55 HDL Selective Delipidation 55 Chronic Kidney 55 neurodegenerative disorder characterized 55 Neuro Oncology SNO 55 Dysregulation 55 triiodothyronine 55 Bronchiolitis 55 Major depressive disorder 55 Antiviral Therapy 55 Newly Diagnosed Multiple Myeloma 55 neuromotor 55 leukemia AML 55 Bone metastases 55 Hypoparathyroidism 55 Cholangiocarcinoma 55 George Ebers 55 nucleotide analog 55 rALLy clinical trial 55 gene MECP2 55 endocrinology gastroenterology 55 Hepatotoxicity 55 Hepatic 55 Kinoid 55 Triapine R 55 Safinamide 55 microsatellite instability 55 clinico pathological 55 myeloproliferative 55 HER2 expression 55 Phase 1b clinical trials 55 Postherpetic neuralgia PHN 55 Severe Sepsis 55 Platinol ® cisplatin 55 solid organ transplantation 55 immuno inflammatory 55 ara C 55 pancreatic islet 55 localized prostate 55 chlamydial 55 HCV Protease Inhibitor 55 PON1 activity 55 urothelial carcinoma 55 acute GvHD 55 kidney allograft 55 chromosomal anomalies 55 oxidized cysteine 55 Squalamine 55 neoplastic diseases 55 ptau 55 Genetic variants 55 metaplasia 55 hepatic lipase 55 Radiographic findings 55 pancreatic lung 55 Acute Coronary Syndromes ACS 55 HER2 neu 55 Bianca Weinstock Guttman 55 advanced hepatocellular carcinoma 55 capillary endothelial cells 55 Glioblastoma Multiforme 55 colorectal adenocarcinoma 55 nasopharyngitis headache 55 anterior pituitary 55 coronary revascularizations 55 multiple myeloma MM 55 embryonal rhabdomyosarcoma 55 ependymoma 55 IMiDs ® compound 55 Coronary artery calcification 55 PDGF B 55 Pleural Mesothelioma 55 cMET 55 Alastair Compston 55 Trandolapril 55 Interpersonal Psychotherapy 55 immunodeficiency disorders 55 LPS induced 55 CEACAM1 55 androgen independent 55 genomic biomarker 55 androgen excess 55 Phase Ib II 55 inherited metabolic disorders 55 Allogeneic 55 p# biomarker 55 Autoimmunity 55 effector function 55 inherited neurodegenerative disorder 55 erythema nodosum 55 pancreatic endocrine 55 cyclophilin inhibitors 55 myotonic muscular dystrophy 55 chemistry microbiology immunology 55 NuroPro ® AD 55 neural progenitor cells 55 antiproliferative effects 55 chronic eosinophilic leukemia 55 Heavy menstrual bleeding 55 IFN ß 55 G6PD deficiency 55 Testosterone deficiency 55 polycystic ovarian disease 55 Spinal cord 55 PDE# inhibitors 55 abnormal uterine bleeding 55 cyclin dependent kinase inhibitor 55 Tyrosine Kinase Inhibitors 55 oral squamous cell 55 narcolepsy cataplexy 55 castrate resistant prostate cancer 55 preclinical efficacy 55 H pylori infection 55 PhG alpha 1 55 imatinib resistance 55 PEG SN# 55 Hashimoto thyroiditis 55 autoantibody positive 55 gastrointestinal GI motility disorders 55 de novo AML 55 Arrhythmogenic Right Ventricular Cardiomyopathy 55 primary biliary cirrhosis 55 fluconazole resistant 55 velafermin 55 acute humoral rejection 55 nonmetastatic 55 malignant prostate 55 Alzheimers Disease 55 Panzem ® 55 lupus erythematosus 55 imatinib therapy 55 retinal degenerative disease 55 Macrophage 55 Phase 2b Trial 55 Bucindolol 55 Lewy Body 55 Henoch purpura 55 activin 55 Infantile Spasms 55 common disabling neurological 55 biostatistical analysis 55 Antitumor 55 herpes zoster shingles 55 TNFalpha 55 Oral mucositis 55 erythropoietic 55 Parkinson disease PD 55 Impaired glucose tolerance 55 near infrared spectroscopic 55 ON #.Na 55 multicentric 55 immunosuppressed patients 55 serine proteases 55 metabolomic profiles 54 paragangliomas 54 allograft rejection 54 ALI ARDS 54 beta carotene supplementation 54 Stent Thrombosis 54 Gynecological Cancer 54 autoimmune thyroiditis 54 immunopathology 54 HepG2 cells 54 LDH lactate dehydrogenase 54 autonomic dysfunction 54 recurrent glioblastoma 54 Decompensated 54 organogenesis 54 lysosomal storage diseases 54 skeletal myoblasts 54 Sjögren Syndrome 54 methylenetetrahydrofolate reductase 54 dysbindin gene 54 MLH1 54 chronic GVHD 54 subcutaneous immunoglobulin 54 circadian rhythm disorders 54 Late Breaker 54 Cannabinoid 54 vasomotor 54 nodal metastasis 54 cytomegalovirus infections 54 ABL1 54 CD# expressing 54 Zweidler McKay 54 vWD 54 juvenile idiopathic arthritis 54 Acute Myelogenous Leukemia AML 54 Chicago Marcella Niehoff 54 ENMD # 54 r hGH 54 HLA DR2 54 basal cell carcinoma BCC 54 metastatic prostate 54 Eosinophils 54 C. trachomatis 54 Echocardiographic 54 Pancreatic 54 Bisphosphonate 54 AlloMap testing 54 TMS Therapy 54 null responder 54 BY EDWARD ZERIN 54 Sven Cnattingius 54 Treg cell 54 interleukins 54 TRIOLEX HE# 54 IMPDH inhibitor 54 TEL AML1 54 glucocorticoid induced osteoporosis 54 pain palliation 54 HLA DR4 immune 54 proteoglycan 54 leucopenia 54 Relapsing remitting MS 54 CEQ# 54 haematologic malignancies 54 ophthalmology dermatology 54 hamartomas 54 Rigorous scientific 54 multiple etiologies 54 Postmenopausal hormone therapy 54 Elevated triglycerides 54 bone marrow aspirates 54 recurrent venous thromboembolism 54 GW# [003] 54 non hodgkin lymphoma 54 polymyalgia rheumatica 54 commercializes innovative biopharmaceuticals 54 Bruxism 54 thrombophilia 54 Carotid Revascularization Endarterectomy vs. 54 Giulio Maria Pasinetti 54 microangiopathy 54 rheumatoid arthritis gout 54 ErbB2 positive 54 B7 H3 54 FGFR1 54 intracranial atherosclerosis 54 anesthesia neuroanatomy obstetrics 54 sCD# 54 Skeletal muscle 54 Non inferiority 54 Prostrate cancer 54 immunology genetics 54 active ankylosing spondylitis 54 valvular heart 54 histopathologic examination 54 2 diabetes T2D 54 Severe Asthma 54 gait disturbance 54 pretransplant 54 Alison Stuebe 54 cutaneous squamous cell carcinoma 54 SCN5A 54 treating psychiatric disorders 54 p#NTR 54 radiosensitivity 54 PTPN# 54 osteoblastic 54 ventricular remodeling 54 Folic acid deficiency 54 Johan Auwerx 54 genitourinary tract 54 serum antibody 54 Vitamin D insufficiency 54 proliferative disorders 54 Endocrine Society #st 54 MGUS 54 cervical lymph nodes 54 Plaque Psoriasis 54 matrix metalloproteinases 54 cutaneous melanoma 54 IL 1ß 54 β amyloid 54 serologically active systemic lupus 54 plasmacytoid 54 trophoblast cells 54 fat malabsorption 54 Rheumatoid 54 Empatic ™ 54 ophthalmology oncology 54 lupus nephritis 54 chemokine receptor 54 mesangial 54 colorectal cancer CRC 54 Laryngeal Cancer 54 agalsidase alfa 54 trap antimatter atoms 54 remyelination 54 rheumatoid arthritis osteoarthritis ankylosing 54 Hp2 2 54 C1q 54 Mantle Cell Lymphoma 54 thyroid carcinoma 54 Generalized anxiety disorder 54 Hepatic Encephalopathy 54 kidney insufficiency 54 oncogenic HPV 54 Pamidronate 54 Posttraumatic 54 Idiopathic Pulmonary Fibrosis 54 euthyroid 54 tumor xenograft models 54 Umbilical cord stem cells 54 rhIL 7 54 Immune Mediated 54 Chronic sinusitis 54 immunosuppression therapy 54 superior mesenteric artery 54 Tesmilifene 54 ICON7 54 Her2 positive 54 Acute Leukemia 54 subsyndromal 54 investigational therapies 54 thymosin beta 4 54 diarrhea headache nausea 54 cultured neurons 54 ALN HTT 54 Interferon beta 54 Neurofibromatosis type 54 HDAC Inhibitor 54 constitutively expressed 54 systemic scleroderma 54 Simulect 54 grade cervical dysplasia 54 dyslipidemic 54 histologies 54 prognostic markers 54 lymphoid cells 54 TLR antagonist 54 lung carcinomas 54 Dasatinib 54 eccrine 54 leukoencephalopathy 54 neuroblastoma tumor 54 Skinvisible receives 54 carcinoid 54 Carcinoid Syndrome 54 neoplastic 54 N. gonorrhoeae 54 Renal Artery 54 Juvenile Idiopathic Arthritis JIA 54 Phase 2b Clinical Trial 54 Myasthenia gravis 54 pyridostigmine 54 JMML 54 Inflammatory Bowel Disease 54 Sarcopenia 54 CD4 + lymphocytes 54 chemoresistant 54 γ secretase 54 Diabetes Complications 54 recurrent glioblastoma multiforme GBM 54 antitumor efficacy 54 MEND CABG 54 trophoblasts 54 Pulmonary Hypertension 54 HNSCC 54 Depressed bipolar 54 STAT3 signaling 54 CMV infections 54 PDGFRA 54 Acute Myelogenous Leukemia 54 hormonal imbalance menopause 54 CD# CD# 54 choroidal vasculopathy 54 Psoriatic arthritis 54 mouse xenograft models 54 tumoral 54 neuro degenerative disease 54 pomalidomide 54 lymphocytic leukemia 54 solid tumors ZYBRESTAT 54 Gorlin syndrome 54 Phase 1a clinical 54 Leber congenital amaurosis 54 Duchenne muscular dystrophy DMD 54 protein tyrosine phosphatase 54 chronic autoimmune disorder 54 PCA3 gene 54 airway hyper responsiveness 54 anti fibrotic 54 cervical carcinoma 54 ARRY # 54 intestinal mucosal 53 carcinoids originate 53 periodontal tissues 53 Fragile X gene 53 leukemia aplastic anemia 53 endothelial activation 53 bFGF 53 unstable angina pectoris 53 Lumbar spinal stenosis 53 allogeneic HSCT 53 neoadjuvant treatment 53 Androxal TM 53 hyperresponsiveness 53 Hair follicle 53 NOD SCID mice 53 Secondhand smoke exposure 53 Joseph Chigona Registrar 53 VEGF induced 53 refractory ovarian cancer 53 cystic kidney 53 EGFR mutant 53 hypermethylated 53 estradiol gel indicated 53 transthyretin amyloidosis 53 neurovascular diseases 53 Novel Inhibitor 53 CRVO 53 Bipolar Mania 53 bladder carcinoma 53 formerly LymphoStat B 53 fosbretabulin 53 Bipolar Disorders 53 gynecologic procedures 53 BR.# 53 HepDirect prodrug 53 underlying pathophysiology 53 visilizumab 53 CIMZIA ™ 53 chromosome #p#.# 53 abstracts summarizing 53 neurological manifestations 53 mouse neural stem 53 oligodendrocyte progenitor cells 53 autosomal dominant disorder 53 multiple sclerosis Crohn disease 53 operable breast cancer 53 Epstein Barr virus EBV 53 Myelodysplastic Syndromes MDS 53 enterococcal 53 Clinical Trials Consortium 53 breast cancer metastasis 53 Limb Salvage 53 receptor antagonism 53 Mermin oversees 53 venous stasis ulcers 53 bronchogenic carcinoma 53 Adult Stem Cell Therapy 53 evaluating Prochymal 53 NKG2D 53 T2DM 53 UCP1 53 circulating endothelial cells 53 pharmacokinetic pharmacodynamic 53 CanAg 53 serum phosphate 53 prospective nonrandomized 53 menstrual dysfunction 53 bronchial epithelial cells 53 ERalpha 53 DMSc 53 XLHED 53 Anticoagulation 53 respiratory allergy dermatological 53 induced anemia 53 CagA 53 VCFS 53 Adrenomyeloneuropathy AMN 53 Vidofludimus 53 RAS mutations 53 entrepreneur futurist 53 node metastases 53 Myelodysplastic syndrome 53 pro angiogenic 53 humoral responses 53 neurogenetic 53 myeloproliferative disorder 53 vWF 53 HIV lipodystrophy 53 cytoprotective 53 poststroke 53 glaucoma ischemia 53 refractory colorectal cancer 53 Demonstrates Sustained 53 ICAAC IDSA 53 familial amyloidotic polyneuropathy FAP 53 gemcitabine Gemzar ® 53 phase IIb study 53 erythropoiesis 53 fronto temporal dementia 53 Renal Cell Carcinoma RCC 53 LTB4 53 Phase 2a Clinical Trial 53 Cell Transplant 53 interferon beta therapy 53 C#Y 53 hypokalemia hypomagnesemia 53 cardio metabolic 53 tuberous sclerosis complex 53 inhibiting tumor 53 radiolabeled TM# 53 DVT PE 53 neuroinflammatory diseases 53 germline mutations 53 idiopathic PAH 53 Biogen Genentech 53 depsipeptide 53 basophils 53 amnestic MCI 53 de novo mutations 53 Paroxysmal Nocturnal Hemoglobinuria 53 nasopharyngeal carcinoma 53 OHR/AVR# 53 hematological malignancy